ASELAGE STEVE

CIK 00012215996 companiesNOVATO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001221599

Recent Transactions

50 trades

Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2024-06-12+49,933→ 49,933 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-06-12+6,820→ 70,159 total
Purchase
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-05-24$6.40/sh+2,500→ 2,500 total
Disposition to Issuer
Acer Therapeutics Inc.
Common Stock, $0.0001 par value per share
2023-11-17−483,741→ 0 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2023-06-13+39,072→ 39,072 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-06-13+16,745→ 63,339 total
Award
Acer Therapeutics Inc.
Stock Option (right to buy)
2023-03-14+20,000→ 20,000 total
Purchase
Acer Therapeutics Inc.
Common Stock
2022-11-29$1.22/sh+409,836→ 483,741 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2022-06-07+30,022→ 30,022 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-06-07+12,866→ 46,594 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-05-31$9.31/sh+569→ 33,728 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-05-11$21.92/sh−2,575→ 146,919 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-02-28$16.61/sh+301→ 33,159 total
Award
Acer Therapeutics Inc.
Stock Option (right to buy)
2022-01-14+18,500→ 18,500 total
Purchase
Acer Therapeutics Inc.
Common Stock
2021-12-10$2.04/sh+7,984→ 73,905 total
Purchase
Acer Therapeutics Inc.
Common Stock
2021-12-09$2.15/sh+2,016→ 65,921 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-11-30$12.06/sh+414→ 32,858 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-11-16$29.39/sh−31,800→ 149,494 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-11-05$16.23/sh+10,000→ 171,794 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-11-05$26.23/sh−10,000→ 161,794 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2021-11-05−10,000→ 70,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-11-02$30.00/sh−3,500→ 19,500 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-11-01$29.48/sh−5,000→ 23,000 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2021-10-07−60,000→ 80,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-10-07$26.23/sh−28,000→ 221,794 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-10-07$16.23/sh+60,000→ 249,794 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-10-07$26.26/sh−32,000→ 189,794 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-08-31$15.92/sh+314→ 32,444 total
Gift
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-07-16+3,000→ 28,000 total
Gift
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-07-16−3,000→ 161,794 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-05-28$15.77/sh+634→ 32,130 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2021-05-25+40,000→ 40,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-05-14+3,000→ 189,794 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2021-05-14+9,000→ 9,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-05-11$19.58/sh−2,146→ 186,794 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2021-04-16−10,000→ 140,000 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-04-16$16.23/sh+10,000→ 198,940 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-04-16$26.23/sh−10,000→ 188,940 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-03-17$27.56/sh−7,727→ 188,940 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2021-03-17−10,000→ 150,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-03-17$27.35/sh−10,000→ 196,667 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-03-17$16.23/sh+10,000→ 206,667 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-02-26$10.78/sh+927→ 31,496 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2021-02-21−25,000→ 275,000 total
Gift
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-04+25,000→ 25,000 total
Gift
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-04−25,000→ 164,794 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-02$10.09/sh+25,000→ 221,667 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-02$30.75/sh−25,000→ 196,667 total
Award
Acer Therapeutics Inc.
Stock Option (right to buy)
2021-01-15+15,000→ 15,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2020-12-15$26.02/sh−5,549→ 196,667 total

ASELAGE STEVE

Recent Transactions

Companies

Recent Filings

Address